Analysis of CYP2C19 gene polymorphism and influencing factors of pharmacological response of clopidogrel in patients with cerebral infarction in Zhejiang, China

BACKGROUND: Certain genetic and non-genetic factors may cause damaged platelet inhibition by clopidogrel. We aimed to determine the effect of cytochrome P4502C19 (CYP2C19) polymorphism, along with other clinical factors, on the platelet response to clopidogrel in patients with acute ischemic stroke...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Yijun, Lu, Yao, Guo, Fei, Wu, Aihua, Weng, Yuesong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931738/
https://www.ncbi.nlm.nih.gov/pubmed/36818341
http://dx.doi.org/10.3389/fcvm.2023.1020593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931738/
https://www.ncbi.nlm.nih.gov/pubmed/36818341
http://dx.doi.org/10.3389/fcvm.2023.1020593

Ejemplares similares